The lipid peroxidation inhibitor, U74006F, was tested for neuroprotective properties using the rat four-vessel occlusion model. Adult Wistar rats (136) were randomized to receive pretreatment with either vehicle or U74006F, and exposed to either 15 min (n = 103) or 5 min (n = 33) of transient but severe forebrain ischemia. Sur viving criterial animals were reperfused for 72 h, and in the multidose experiments, animals were injected with repeated doses of U74006F or vehicle during the reperfu sion period. Vehicle-treated animals exposed to 15 min of ischemia sustained 60 ± 35% (n = 16) CA l pyramidal cell necrosis whereas U74006F-treated animals lost 61 ± 30% (3 mg/kg, n = 9),42 ± 35% (10 mg/kg, n = 15),62 ± 28% (5 x 10 mg/kg, n = 10), and 74 ± 30% (8 x 10 mg/kg, n Postischemic selective neuronal damage affects specific populations of cells, the CA. and CA4 py ramidal cells, the medium and small striatal cells, and cortical neurons in layers 3, 5, and 6 (Pulsinelli et aI., 1982). Morphologically evident damage to these cells, which occurs without associated dam age to glia, ependymal tissue, and neurovascula ture, occurs after a delay: �6 hours in the striatum, �24 hours in the cortex, and 48-72 h in the hippo campus (Kirino, 1982; Pulsinelli et aI., 1982). Both this anatomic selectivity and the heterogeneous temporal maturation remain unexplained. Recently, much emphasis has been placed on the "excitotoxic hypothesis" and, although N-methyl-o-aspartate (NMDA) antagonists have been demonstrated to
= 10) of CA l pyramidal cells. No improvement was seen in the injury to cortex or striatum with either pre-or pre and posttreatment with U74006F. For animals suffering 5 min of transient forebrain ischemia, vehicle-treated rats lost 19 ± 26% (n = 14), whereas U74006F-treated (8 x 10 mg/kg) animals lost 36 ± 39% (n = 15) of CA l neurons. In addition, no protection was discerned in the mildly in jured striatum or cortex of these animals. Given the po tent effect of U74006F in inhibiting iron-dependent lipid peroxidation in vitro, we question the importance of oxy radicals in the mechanism of postischemic selective neu ronal injury in vivo. Key Words: Global ischemia-Four vessel occlusion-Lipid peroxidation inhibitor-Stroke Rat.
prevent neuronal injury, the data remain controver sial (for review see Buchan, 1990) . The severity of the damage depends clearly upon the absolute re duction of forebrain cerebral blood flow, the dura tion of this reduction, the duration of reperfusion, and the temperature of the brain parenchyma at the time of the ischemic insult and during the initial period of reperfusion (Busto et aI., 1987; Buchan and Pulsinelli, 1990; Kuroiwa et aI., 1990) .
The development of the 21-amino steroid lipid peroxidation inhibitor U74006F (21 [4-(2,6-di-l pyrolidinyl-4-pyrimidinyl)-1-piperazinyl]-16-a methylpregna-I ,4, 9( II )-triene-3 ,20-dione monomethane sulfonate) has afforded a pharmaco logical tool to test the concept that lipid peroxida tion-generated oxy radicals mediate postischemic neuronal injury (Braughler et aI., 1987 (Braughler et aI., , 1988 . A number of animal studies have suggested that the drug is an effective form of prophylaxis, reducing mortality by attenuating ischemia-induced neuronal damage to the hippocampus and the cortex (Hall et aI., 1988a,' Hall and Pazara, 1989) . The drug has been tested in gerbil (Hall et aI., 1988a) , cat and dog (Natale et aI., 1988; Perkins et aI., 1989 ) models of global ischemia and also in rat models of focal ischemia through occlu sion of the middle cerebral artery (Young et aI., 1988; Xue et aI., 1990) . The positive results using this potent lipid peroxidation inhibitor suggest free radical-mediated damage occurs in the reperfusion period and, given U74006F's beneficial effect in the absence of any overt toxicity, lend support to the predicted clinical trials.
These studies were undertaken to see if the drug could prevent neuronal damage in the hippocam pus, striatum, and cortex using a well-studied model of transient but severe forebrain ischemia in the unanesthetized adult rat (Pulsinelli and Brierley, 1979) . The results of these experiments have been presented in part in abstract form (Xue et al., 1990) .
METHODS

Four-vessel occlusion preparative surgery
Adult male Wi star rats weighing 175-275 g were used in the experiments. Transient forebrain ischemia was achieved using a modification (Pulsinelli and Duffy, 1983; Pulsinelli and Buchan, 1988) of the four-vessel occlusion model (Pulsinelli and Brierley, 1979) . The methods have recently been described in detail (Buchan et aI., \991) . In brief, animals were anesthetized with halothane. Both common carotid arteries were exposed through a ventral midline cervical incision and lengths of atraumatic silas tic ligature tied loosely around the arteries. A silk ligature was passed through the neck, posterior to the trachea, esophagus, external jugular veins, common carotid arter ies, and carotid nerves, but anterior to the cervical and paravertebral musculature, utilizing a spinal needle. The ventral incision was closed with a surgical clip and the ends of the silk ligature taped to the nape of the neck.
A second incision was made occipitally, the paraspinal muscles separated to expose the alar foramina, and the vertebral arteries electrocauterized. The wound was su tured and, after recovery from anesthesia, the animals were allowed water but not food until the following morn ing.
Ischemia
Following local anesthesia to the ventral wound, the animals were gently restrained, the surgical clip removed, and the ligatures surrounding the carotid arteries tight ened, resulting in four-vessel occlusion. Loss of con sciousness was seen within 10-15 s, associated with run ning behavior and loss of righting reflexes. The ligature surrounding the paravertebral musculature was then tightened to prevent the opening of collateral bloodflow channels, and to ensure that the pupils became bilaterally fixed and dilated. A rectal temperature probe was in serted into each animal, taped to the tail and connected to a YSI temperature controller attached to a heat lamp, which maintained temperature at 37.5 ± O.saC throughout the ischemic period.
Animals were observed throughout the ischemic inter val, at the end of which they were checked for unrespon-siveness and dilated pupils. The carotid ligatures were removed, the carotid arteries inspected for patency and the wound closed with a surgical clip. Comatose animals were returned to their cages with a rectal probe in situ so that temperature could be maintained throughout the re covery period (1-3 h for 15 min of ischemia and 15-45 min for 5 min of ischemia). Animals which did not remain unresponsive throughout the ischemic period, those whose temperature dropped to <37.0°C, and those who developed seizures or died were excluded from the study.
Experimental paradigms
In the 15-min ischemia, single-dose treatment para digm, animals received an intraperitoneal (IP) injection of U74006F at doses of either 3 or 10 mg/kg 30 minutes before ischemia. Control animals received an equal vol ume of vehicle (0.5-1.3 ml IP) 30 min before the ischemic insult.
In the 15 min ischemia, multiple-dose treatment para digm, U74006F, 10 mg/kg IP, was given 30 min before ischemia and at 6, 18, 30, and 48 h postischemia. A sec ond group received a total of eight injections, 30 min pre treatment with 10 mg/kg and posttreatment at 2, 4, 6, 8, 10, 22, and 34 h following ischemia. Control animals were given equivalent volumes of vehicle according to the same dose schedule.
In a separate experiment, the ischemic period was re duced to 5 min and animals were treated with U74006F or vehicle 30 min before ischemia and subsequently post treated at 2, 4, 6, 8, 10, 22, and 34 h following ischemia with either U74006F (10 mg/kg IP) or an equivalent vol ume of vehicle.
Neuropathological analysis
Following ischemia all animals were allowed to recover (temperature maintained at 37.saC for an initial 4-6 h postischemia) and given free access to food and water for a reperfusion period of 72 h. Animals were perfusion fixed by cannulating the ascending aorta, flushing blood out with heparinized saline, and then an infusion of 40% formaldehyde/glacial acetic acid/methanol (F AM) 1: 1:8 with the right atrium opened. Brains were left in situ at 4°C overnight; coronal sections of paraffin-embedded brain 7 !-Lm thick were cut at several levels of the dorsal hippocampus (3.6 and 4. 1 mm caudal to the bregma), and striatal and cortical injury was assessed at 0.2 and 1.6 mm rostral to the bregma (Paxinos and Watson, 1986) . Sec tions were stained with haematoxylin and eosin.
The identity of treatment groups was concealed during the histological examination. The CAl region of the hip pocampus was assessed by counting both the number of histologically normal-and abnormal-appearing CAl neu rons. Sections from the two different coronal levels of dorsal hippocampus for each animal were quantified. Ir reversible ischemic damage was accepted in any neuron showing a shrunken appearance with an eosinophilic cy toplasm and a dark pyknotically staining nucleus, or in neurons that had progressed to homogenizing changes or naked nuclei (Brierley, 1976; Brown, 1977) . The results are expressed as a percentage of dead neurons, defined as [(total CAl neurons -normal CAl neurons)/total CAl neurons] x 100.
The cortex and striatum were also graded for neuronal damage using a semiquantitative scale (0 = normal, 1 < 10%, 2 = 10-50%, and 3 > 50% injured neurons).
Statistical analysis
Differences in the percentage of dead CA l neurons and in grades of damage in the cortex and striatum were an alyzed by nonparametric statistics with the Kruskal Wallis test, and individual comparisons were then made with the Mann-Whitney U test using a Bonferoni correc tion. Differences in arcsin and logit (Zar, 1984; Armitage and Berry, 1987 )-transformed percentages of dead CA l were also analyzed with both nonparametric (Kruskal Wallis and Mann-Whitney U with Bonferoni correction) and parametric (Student's t, analysis of variance, and Dunnett multiple comparisons) tests.
An a priori sample size calculation was performed us ing control data from our laboratory. We calculated that in order to detect a 30% reduction in hippocampal CA l injury, accepting an alpha of 0.05 and a beta of 0.2, 10 animals per group would be needed in the 15-min exper iment and 14 animals per group would be needed in the 5-min experiment.
RESULTS
U74006F produced no noticeable behavioral ef fects. As can be seen in Table 1 , increasing doses of the drug had no adverse effect on either morbidity or mortality. The numbers of animals that were noncriterial and died were within the expected range from previous experience. Deaths occurred through respiratory arrest during the four-vessel oc clusion or from seizures during the reperfusion pe riod. The number of animals dying and judged non criterial were equally distributed in the different groups. Animal outcome is presented in Table 1 .
Rectal temperature was maintained at 37.5 ± OSC throughout the ischemic interval and the post ischemic coma; mean intraischemic rectal temper atures are presented in Table 2 . There were no sig nificant differences in temperature between the dif ferent groups pre-, during, or postischemia. Figure 1 presents the percentage of dead CAl neurons for the means of the left and right hippo campi of each animal and also the mean damage (±SD) for each of the treatment groups. In the ve-hicle-treated animals exposed to 15 min of isch emia, those given single doses (n = 8) and those given multiple doses (n = 8) showed no histological differences, and they were therefore pooled (n = 16). Single-dose U74006F pretreatment (either 3 or 10 mg/kg) had no significant effect on hippocampal damage in those animals subjected to 15 min of isch emia. There were also no differences in the percent age of hippocampal damage for those animals given five and eight doses of U74006F (10 mg/kg). In Ta ble 3 is shown the amount of hippocampal, cortical, and striatal injury for the 15-min ischemia animals.
No statistically significant differences were deter mined for any of the drug-treated groups compared with vehicle-treated animals. These data were more variable than had been predicted, but post hoc anal ysis indicates that a 40% difference would have been detected (had one existed) with 10 animals in each group. There was � 18% less damage in the 10 mg/kg single-dose pretreatment group, but �50 an imals per group would have been needed to be sure that this slight protection was significant and not missed by a type II error. As no such protection or trend was seen with the higher doses, i.e., 10 mg/kg given 5 or 8 times, we did not proceed to increase the number of animals in this group.
In Table 3 the amount of neuronal damage for 5-min ischemic animals is also shown. Damage to the hippocampus, cortex, and striatum following 5 min of ischemia was mild but not discernibly differ ent between animals treated with vehicle and those treated with U74006F. Five minutes of four-vessel occlusion ischemia caused significantly less (p < 0.01) CAl damage compared with animals exposed to 15 min of forebrain ischemia. No difference was discerned in the amount of hippocampal damage between animals treated with vehicle and those treated with eight doses of 10 mg/kg U74006F. The variance of these vehicle-treated animals indicates that, with the number of animals used, a 27% I  I  0  I  0  I  00  I 0  I  0  I  I  I  0  I  I  I  I  I  I  I  I  0  I  I  I  I  I  I  I  0  I  0 I  I  I  I  I  I  0  I  0  I  I  I  0  I  0  I  0  I  1  0  I where vascular injury may play a more important role (Siesj6 et aI., 1990) .
Published reports on the 21-amino steroid U74006F have shown that in vitro it is a potent inhibitor of iron-dependent lipid peroxidation, act ing as a lipophilic steroid exerting cell membrane stabilizing effects, while lacking a glucocorticoid re sponse (Braughler et aI., 1987 (Braughler et aI., , 1988 Braughler and Pregenzer, 1989) . In vitro, U74006F inhibits lipid peroxidation via a direct antioxidant mechanism, inhibiting free radical-mediated arachidonic acid re lease and the production of free radicals (Braughler et aI., 1988; Braughler and Pregenzer, 1989 ). The evidence for U74006F's lipid peroxidation inhibi tory properties in vivo is less compelling. Indirect evidence is suggested by its ability to preserve vi tamin E levels during postischemic reperfusion (Hall et aI., 1991) . Decreased vitamin E levels were detected 2 h after reperfusion, i.e., before histolog ical injury was apparent, suggesting that a decrease in levels of vitamin E portend critical events in the pathogenesis of injury rather than simply reflecting tissue degeneration. Another example of U74006F's lipid peroxidation activity in vivo is demonstrated in a model of subarachnoid hemorrhage (Kanamaru et aI., 1991) by the observation that in 7-day-old subarachnoid clots, levels of the peroxide product malonaldehyde were lower in monkeys given U74006F as compared with those given vehicle.
That lipid peroxidation is important in the pro cess of selective ischemic neuronal death is depen dent on the postischemic production of lipid perox idation products and the yet-to-be-demonstrated presence of highly reactive molecules such as su peroxide ion, hydrogen peroxide, and hydroxyl rad icals (Siesj6 et aI., 1990) . During brain ischemia there is a reduction in the concentration of the en dogenous antioxidants ascorbate, glutathione, and a-tocopherol (vitamin E); this consumption sug- Vol. 12, No.2, 1992 gests an attempt to quench ischemia-induced free radicals, affording indirect evidence of their pro duction (Hall et aI., 1989 (Hall et aI., , 1991 . Vitamin E losses are indicative not only of lipid peroxidation: vitamin E can also intercept oxygen radicals directly (Siesj6 et aI., 1990) . Lipid peroxide levels remain unaltered in all brain regions during ischemia, but they do increase following reperfusion (Watson et aI., 1984) , particularly in ischemia-sensitive regions (hippocampus, striatum, and cortex) (Bromont et aI., 1989) . The study by Bromont et al. utilized the four-vessel occlusion model, evaluating lipid perox ides by measuring thiobarbituric acid-reactive sub stances, and found increases in the hippocampus, striatum, and cortex between 8 and 72 h after isch emia. No increases were found early, i.e. at 1 h, raising the concern that the increases in peroxide products represent a late phenomenon rather than a critical event in the cascade that results in ischemic neuronal injury. Another study, which utilized the four-vessel occlusion model, failed to observe any increases in cortical peroxide levels during reperfu sion (MacMillan, 1982) .
Direct evidence that free radicals are produced during either cerebral ischemia or reperfusion is limited, and comes from changes in the electron spin resonance spectrum of brain samples from rats treated with the oxygen free radical spin trap phe nyl-t-butyl-nitrone (Kirsch et al., 1987) . The protec tive action of the radical scavenger, superoxide dis mutase, has been demonstrated in cat models of both focal (Davis et aI., 1987) and global (Snelling et aI., 1987) ischemia. In both instances superoxide dismutase not only improved cerebral blood flow but also enhanced neurophysiological recovery.
U74006F has been tested in the gerbil in two dif ferent ischemic paradigms: a unilateral 3-h carotid occlusion model and a 15-min bilateral carotid oc clusion model. Animals were treated with 3 or 10 mg/kg U74006F IP, and survival was dramatically improved in a dose-dependent fashion (Hall et ai. , 1988a) . The neuronal densities were examined in the hippocampus CAl subfield and the medial and lateral cerebral cortex in gerbils surviving 24 h fol lowing unilateral carotid artery occlusion. Compar isons of the neuronal densities in the ischemic hemi sphere with those in the contralateral nonischemic hemisphere revealed significant neuronal preserva tion for all three brain regions when animals were treated with U74006F at 10 mg/kg IP immediately before and 3 h following unilateral carotid occlusion (Hall et ai. , 1988a) . However, with bilateral carotid occlusion utilizing 15 min of severe transient fore brain ischemia, doses of U74006F 30 min before and 3 h after ischemia, with histological examination at one week, showed no positive effect on neuronal loss in the CAl region of the hippocampus (Hall and Pazara, 1989 ). There was a 75% reduction of hip pocampal neurons whether animals were treated with 1, 10, or 30 mg/kg U74006F pre-and postis chemia.
U74006F has also been examined following car diopulmonary arrest in dogs and shown to reduce mortality and the sensory motor deficit following transient global cerebral ischemia, but no histolog ical data were presented (Natale et ai. , 1988; Per kins et ai. , 1989) . In cats, U74006F improved post ischemic cortical hypoperfusion, resulting in im proved recovery of somatosensory evoked potentials . Other studies have concerned the use of MCAo and U74006F in a cat model, and suggest that not only is the volume of infarction reduced but also that ischemic changes in brain water and ion composition are favorably influenced by the 21-amino steroid. There is a re duction of sodium accumulation, potassium loss, and water entry in the regions surrounding the in farct, but not in the core of the infarction (Young et ai. , 1988) . This implies that U74006F is able to in fluence the surrounding area more than the core.
We have recently reported that in focal ischemia, U74006F reduces the volume of infarction in a reperfusion or temporary, but not a permanent, MCAo model (Xue et ai. , 1992) .
In summary, previous studies have shown that U74006F has a capability of reducing injury to the nervous system from injections of arachidonic acid (Hall and Travis, 1988a) , in models of vasospasm (Hall and Travis, 1988b; Vollmer et a\. , 1989; Zuc carello and Anderson, 1989; Zuccarello et aI. , 1989) , in models of trauma (Anderson et ai. , 1988; Hall, 1988; Hall et aI. , 1988b Hall et aI. , , 1989 , and, in partic ular, in models of focal (Hall et ai. , 1988a; Xue et ai. , 1990; Young et ai. , 1988) and global (Natale et ai. , 1988; Perkins et aI. , 1989 ) cerebral ischemia.
Furthermore, pretreatment with U74006F in global ischemia results in maintenance of endogenous vi tamin E levels, providing indirect evidence for U74006F's putative in vivo role as a lipid peroxida tion inhibitor (Hall et aI. , 1991) . However, in our model of severe forebrain ischemia, we were unable to demonstrate that the drug had a protective effect on the resulting histopathology, despite going to ex tremely high dosage schedules. We conclude that, although the drug U74006F may be important in blocking mechanisms that lead to brain injury such as neocortical infarction following transient focal ischemia, it does not prevent selective neuronal death. Although U74006F is active in vivo as a lipid peroxidation inhibitor, these experiments do not support the view that lipid peroxidation-mediated injury to the cell membrane is important in selective neuronal injury following transient forebrain isch emia, nor do they support the use of U74006F as a neuronal cytoprotectant in the setting of successful resuscitation from cardiac arrest.
